These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31170512)

  • 1. Development of Halobetasol-loaded nanostructured lipid carrier for dermal administration: Optimization, physicochemical and biopharmaceutical behavior, and therapeutic efficacy.
    Carvajal-Vidal P; Fábrega MJ; Espina M; Calpena AC; García ML
    Nanomedicine; 2019 Aug; 20():102026. PubMed ID: 31170512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid carriers loaded with Halobetasol propionate for topical treatment of inflammation: Development, characterization, biopharmaceutical behavior and therapeutic efficacy of gel dosage forms.
    Carvajal-Vidal P; González-Pizarro R; Araya C; Espina M; Halbaut L; Gómez de Aranda I; García ML; Calpena AC
    Int J Pharm; 2020 Jul; 585():119480. PubMed ID: 32479897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
    Nagaich U; Gulati N
    Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Different Skin Penetration Promoters in Halobetasol Propionate Permeation and Retention in Human Skin.
    Carvajal-Vidal P; Mallandrich M; García ML; Calpena AC
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K
    Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556
    [No Abstract]   [Full Text] [Related]  

  • 7. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
    Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
    J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characteristics of monostearin nanostructured lipid carriers.
    Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
    Int J Pharm; 2006 May; 314(1):83-9. PubMed ID: 16563671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of a film-forming system hybridized with econazole-loaded nanostructured lipid carriers for enhanced antifungal activity against dermatophytes.
    Na YG; Huh HW; Kim MK; Byeon JJ; Han MG; Lee HK; Cho CW
    Acta Biomater; 2020 Jan; 101():507-518. PubMed ID: 31629894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: Formulation characterization and assessment of dermal delivery compared to referent ointment.
    Savić V; Ilić T; Nikolić I; Marković B; Čalija B; Cekić N; Savić S
    Int J Pharm; 2019 Oct; 569():118624. PubMed ID: 31419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved tacrolimus skin permeation by co-encapsulation with clobetasol in lipid nanoparticles: Study of drug effects in lipid matrix by electron paramagnetic resonance.
    Andrade LM; Silva LAD; Krawczyk-Santos AP; Amorim ICSM; Rocha PBRD; Lima EM; Anjos JLV; Alonso A; Marreto RN; Taveira SF
    Eur J Pharm Biopharm; 2017 Oct; 119():142-149. PubMed ID: 28627400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
    Baek JS; Pham CV; Myung CS; Cho CW
    Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma.
    Qidwai A; Khan S; Md S; Fazil M; Baboota S; Narang JK; Ali J
    Drug Deliv; 2016 May; 23(4):1476-85. PubMed ID: 26978275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil.
    Rajinikanth PS; Chellian J
    Int J Nanomedicine; 2016; 11():5067-5077. PubMed ID: 27785014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
    Khurana S; Jain NK; Bedi PM
    Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery.
    Bikkad ML; Nathani AH; Mandlik SK; Shrotriya SN; Ranpise NS
    J Liposome Res; 2014 Jun; 24(2):113-23. PubMed ID: 24131382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clobetasol-loaded nanostructured lipid carriers for epidermal targeting.
    Silva LA; Andrade LM; de Sá FA; Marreto RN; Lima EM; Gratieri T; Taveira SF
    J Pharm Pharmacol; 2016 Jun; 68(6):742-50. PubMed ID: 27061573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synergistic approach of adapalene-loaded nanostructured lipid carriers, and vitamin C co-administration for treating acne.
    Jain A; Garg NK; Jain A; Kesharwani P; Jain AK; Nirbhavane P; Tyagi RK
    Drug Dev Ind Pharm; 2016; 42(6):897-905. PubMed ID: 26577703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.